Our Future Is Biotech

A Plain English Guide to How a Tech Revolution is Changing Our Lives and Our Health for the Better

プレビューの再生

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

聴き放題対象外タイトルです。Audible会員登録で、非会員価格の30％OFFで購入できます。

￥2,380で会員登録し購入

無料体験で、20万以上の対象作品が聴き放題に

アプリならオフライン再生可能

プロの声優や俳優の朗読も楽しめる

Audibleでしか聴けない本やポッドキャストも多数

無料体験終了後は月額￥1,500。いつでも退会できます。

Our Future Is Biotech

著者： Andrew Craig

ナレーター： Andrew Craig

￥2,380で会員登録し購入

無料体験終了後は月額￥1,500。いつでも退会できます。

￥3,400 で購入

既定としてのお支払い方法が選択されていません。

支払方法を追加する

支払方法を変更する

申し訳ありません。選択されたお支払い方法では、このタイトルをご購入いただけません。

支払方法を変更する

下4桁がのクレジットカードで支払う

支払方法を変更する

ボタンを押すと、Audibleの利用規約およびAmazonのプライバシー規約同意したものとみなされます。支払方法および返品等についてはこちら。

キャンセル

このコンテンツについて

"An essential read for anyone committed to understanding the technologies that will define our future." CHRISTIAN ANGERMAYER, BIOTECH ENTREPRENEUR AND FOUNDER OF APEIRON INVESTMENT GROUP

Welcome to the biotech revolution

In the last century, technology has transformed the human experience across the world. This has been super-charged by the arrival of the internet, smart phones, AI and machine learning, and created trillion-plus dollar companies and household names like Apple, Amazon, Google and Microsoft.

Our Future is Biotech explains why biotech is next: because our biggest remaining challenges as a species concern biological systems.

Biotech companies will solve our most intractable problems, from cancer, dementia, obesity and diabetes to elderly care, mental health conditions, and even clean power generation, agricultural production and environmental degradation.

Biotech means that we can all live better, safer, healthier, wealthier, happier, and longer lives.

The industry has already delivered "miracle cures" for several diseases, and there is more to come. But despite this, few people are aware of the phenomenal progress being made. Our Future is Biotech addresses this, explaining what biotech is, what is coming next, and how you might profit from it too.

Tech has been the most important theme for human progress for the last century. Biotech is next.

PLEASE NOTE: When you purchase this title, the accompanying PDF will be available in your Audible Library along with the audio.

バイオテクノロジー

ビジネス・キャリア

遺伝子

遺伝学

批評家のレビュー

"A tour-de-force and a book that I found unputdownable. Andrew has seen the way for biotech and brings a unique, insightful and typically plain-English perspective to us all. This is a must read and highly recommended." (Barry Smith, Founder of Sunday Times’ Fast Track 100 probiotics company, Symprove)

"An excellent analysis of the life-changing scientific developments occurring in the world right now and a good prod in the ribs to Governments and Regulators to improve the funding environment to ensure we all benefit!" (Jim Wilkinson, CFO, Oxford Science Enterprises)

"This is an important and extremely timely book which covers many key aspects of the biotech industry. Andrew provides excellent context for all readers no matter what level of knowledge and dives with appropriate depth into so many important areas of dramatic innovation. I thoroughly recommend this book as a clear guide for anyone interested in the sector and its impact on all of us, now and in the future." (David Browning, biotech industry veteran and former Chairman of Oxford Bioscience Network (OBN))

"In a world of ever-greater complexity, biotechnology is at the forefront of the complex. From the medicines we take, to the medical devices that are implanted, to the myriad of apps directing our diet and exercise regimes. Every day we are impacted by the products of this 'biotech revolution'. Even those who specialise in biotechnology can struggle to keep up! Our Future is Biotech is an outstanding, easy to read, anatomy of the impacts that biotechnology will have on all of us, what we need to understand and what we might need to do about it. I urge anyone with an interest in the future to read it!" (Dr Eliot Forster, Professor of Molecular and Clinical Cancer Medicine at the University of Liverpool, CEO of Levicept and Chairman of Avacta plc)